Ülke: ABD
Dil: İngilizce
Kaynak: NLM (National Library of Medicine)
CEFTRIAXONE SODIUM (UNII: 023Z5BR09K) (CEFTRIAXONE - UNII:75J73V1629)
Sandoz GmbH
CEFTRIAXONE SODIUM
CEFTRIAXONE 250 mg
INTRAMUSCULAR
PRESCRIPTION DRUG
Before instituting treatment with ceftriaxone, appropriate specimens should be obtained for isolation of the causative organism and for determination of its susceptibility to the drug. Therapy may be instituted prior to obtaining results of susceptibility testing. To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, USP and other antibacterial drugs, ceftriaxone for injection, USP should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. Ceftriaxone for injection, USP is indicated for the treatment of the following infections when caused by susceptible organisms: Caused by Streptococcus pneumoniae , Staphylococcus aureus, Ha
Ceftriaxone for injection, USP is supplied as a sterile crystalline powder in glass vials. The following packages are available: Vials containing 250 mg equivalent to ceftriaxone. Package of 10 (43858-631-01). Vials containing 500 mg equivalent to ceftriaxone. Package of 10 (43858-632-01). Vials containing 1 g equivalent to ceftriaxone. Package of 10 (43858-633-01). Vials containing 2 g equivalent to ceftriaxone. Package of 10 (43858-634-01). Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from light.
Abbreviated New Drug Application
CEFTRIAXONE SODIUM- CEFTRIAXONE SODIUM INJECTION, POWDER, FOR SOLUTION SANDOZ GMBH ---------- CEFTRIAXONE FOR INJECTION, USP Rx only To reduce the development of drug-resistant bacteria and maintain the effectiveness of ceftriaxone for injection, and other antibacterial drugs, ceftriaxone for injection should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria. DESCRIPTION Ceftriaxone for injection, USP is a sterile, semisynthetic, broad-spectrum cephalosporin antibiotic for intravenous or intramuscular administration. Ceftriaxone sodium is (6_R_, 7_R_)-7-[2-(2-Amino-4-thiazolyl) glyoxylamido]-8-oxo-3-[[(1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-_as_-triazin-3-yl)thio]methyl]-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7 -(_Z_)-(_O_-methyloxime), disodium salt, sesquaterhydrate. The chemical formula of ceftriaxone sodium is C H N Na O S •3.5H O. It has a calculated molecular weight of 661.60 and the following structural formula: Ceftriaxone sodium is a white to yellowish crystalline powder which is readily soluble in water, sparingly soluble in methanol and very slightly soluble in ethanol. The pH of a 1% aqueous solution is approximately 6.7. The color of ceftriaxone sodium solutions ranges from light yellow to amber, depending on the length of storage, concentration and diluent used. Each vial contains ceftriaxone sodium equivalent to 250 mg, 500 mg, 1 gram or 2 grams of ceftriaxone activity. Ceftriaxone sodium contains approximately 83 mg (3.6 mEq) of sodium per gram of ceftriaxone activity. CLINICAL PHARMACOLOGY Average plasma concentrations of ceftriaxone following a single 30-minute intravenous (IV) infusion of a 0.5, 1 or 2 g dose and intramuscular (IM) administration of a single 0.5 (250 mg/mL or 350 mg/mL concentrations) or 1 g dose in healthy subjects are presented in TABLE 1. TABLE 1. CEFTRIAXONE PLASMA CONCENTRATIONS AFTER SINGLE DOSE ADMINISTRATION AVERAGE PLASMA CONCENTRATIONS (MCG/ML) 2 18 16 8 2 7 3 2 * DOS E/ROUTE 0.5 HR 1 HR 2 HR 4 Belgenin tamamını okuyun